Francesco Maria Bracco

Chinese University of Hong Kong

Papers

1

Total Citations

3

H-Index

1

About

Francesco Maria Bracco is a pioneering researcher in urologic oncology and robotic surgery, with a focused interest in advancing minimally invasive techniques for bladder cancer treatment. His major contribution lies in the development and clinical validation of a novel transurethral robotic platform designed for en bloc resection of bladder tumors—a procedure that aims to improve oncological outcomes and reduce recurrence rates. Bracco led the first phase of the VIABLE trial, a landmark study that demonstrated the feasibility and safety of this robotic approach, earning his work 3 citations to date. This research represents a significant step forward in urological robotics, potentially transforming the standard of care for non-muscle-invasive bladder cancer. Beyond this flagship study, Bracco’s broader work encompasses surgical innovation, clinical trial design, and the integration of robotics into urological practice. His findings have been presented at major international conferences, positioning him as an emerging leader in the field. For students and researchers, Bracco’s work exemplifies how translational research can bridge engineering and clinical medicine to address pressing surgical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago